Determination

Project Determination

Core State Injury and Violence Prevention Program (SIPP) Evaluation

Project ID:	0900f3eb81cb9553
Accession #:	NCIPC-PIEB-3/3/21-b9553
Project Contact:	Brandon Nesbit
Organization:	NCIPC/OD/OS
Status:	Pending Regulatory Clearance
Intended Use:	Project Determination
Estimated Start Date:	08/01/21
Estimated Completion Date:	07/31/26
CDC/ATSDR HRPO/IRB Protocol#:
OMB Control#:

Description

Priority

Standard

Date Needed

03/31/21

Determination Start Date

03/03/21

Description

This Notice of Funding Opportunity (CDC-RFA-CE21-2101) supports health department infrastructure, data and partnerships to identify and respond to existing and emerging injury threats with data-driven public health actions. These actions are intended to increase protective factors and reduce risk factors using the best available evidence for injuries and death. Such an approach includes engaging in robust data and surveillance, strengthening strategic collaborations and partnerships, and conducting assessment and evaluation. The overall goal of this approach is to inform public health action for injury prevention. An enhanced funding component is available for recipients to implement and evaluate prevention strategies while incorporating novel surveillance activities, with the goal of contributing practice-based evidence to strengthen the overall evidence base for injury prevention. While all recipients will focus their strategic efforts on prevention of traumatic brain injury (TBI), transportation-related injury, and Adverse Childhood Experiences (ACES), recipients are also encouraged to examine their data and flex up to 25% of their award to address identified priority injury topics of local concern (i.e. drowning, older adult falls, or suicide). This project determination is specific to the Core SIPP evaluation only. The NOFO has already been cleared.

IMS/CIO/Epi-Aid/Lab-Aid/Chemical Exposure Submission

No

IMS Activation Name

Not selected

Select the primary priority of the project

Not selected

Select the secondary priority(s) of the project

Not selected

Select the task force associated with the response

Not selected

CIO Emergency Response Name

Not selected

Epi-Aid Name

Not selected

Lab-Aid Name

Not selected

Assessment of Chemical Exposure Name

Not selected

Goals/Purpose

This evaluation is designed to assess recipients' capacity to strengthen public health infrastructure, data, and partnership to identify and respond to existing and emerging injury threats with data-driven public health actions in their jurisdictions. The evaluation will measure a)changes in recipients capacity to implement public health actions b)leveraged funds and resources as a result of Core SIPP funding c)Impact of implementation and evaluation efforts.

Objective

Evaluate and describe the impact of Core SIPP funding on 1) Recipients' capacity to strengthen public health infrastructure, data, and partnership to identify and respond to existing and emerging injury threats with data-driven public health actions in their jurisdictions. 2) Decrease injury related morbidity and mortality in priority topic areas (MV, TBI, ACEs) in funded jurisdictions.

Does this project include interventions, services, or policy change work aimed at improving the health of groups who have been excluded or marginalized and/or decreasing disparities?

Not Selected

Project does not incorporate elements of health equity science

Not selected

Measuring Disparities

Not selected

Studying Social Determinants of Health (SDOH)

Not selected

Assessing Impact

Not selected

Methods to Improve Health Equity Research and Practice

Not selected

Other

Not selected

Activities or Tasks

Programmatic Work

Target Population to be Included/Represented

General US Population

Tags/Keywords

Program Evaluation

CDC's Role

CDC provides technical assistance but does not specifically request or approve study design or data collection

Method Categories

Individual Interviews (Qualitative); Secondary Data Analysis; Surveillance Support; Technical Assistance

Methods

Mixed methods design including a)individual interviews with recipients b)annual reporting on activities, performance measures, evaluation indicators, leveraged resources and funds, and implementation capacity enhancements c)submission of jurisdiction level surveillance data. All analysis will be secondary analysis on data collected and submitted by recipients or primary analysis on data collected directly from funded recipients.

Collection of Info, Data, or Bio specimens

Qualitative data will be collected through in-person or virtual interviews and narrative forms on annual progress reporting. Interviews will occur once a year with individual recipients to capture information on a broad range of program efforts, challenges, and successes to inform continuous quality improvement, technical assistance administration, and program impact. Quantitative data will be collected via the Partners Portal (web-interface) or excel documents submitted as part of the annual progress reporting and evaluation requirements. Annually recipients will submit information on public health actions, evaluation indicators, and success stories. We will be collecting data on leveraged resources and funds through excel templates developed in collaboration with the Econ Team in DIP. Data on implementation capacity enhancements will be collected through rubric style reporting in the Partners Portal. Aggregate surveillance data will be collected via Injury Indicator and special emphasis reports submitted annually.

Expected Use of Findings/Results and their impact

Evaluation results will be used to inform programmatic improvement, technical assistance, and program impact. Programmatic improvements will be made within cycle and across funding cycles, both for individual recipients and across recipients. Findings will be used to inform technical assistance at both the recipient level and program level. Impact of program funding will be used to communicate with CDC leadership and other stakeholders and to inform the evidence base and future implementation efforts.

Could Individuals potentially be identified based on Information Collected?

No

Funding
Funding Type	Funding Title	Funding #	Original Fiscal Year	# of Years of Award	Budget Amount

HSC Review

HSC Attributes

Program Evaluation

Yes

Regulation and Policy

Do you anticipate this project will be submitted to the IRB office

No

Institutions
Institution	FWA #	FWA Exp. Date	IRB Title	IRB Exp. Date	Funding #

Staff
Staff Member	SIQT Exp. Date	Citi Biomedical Exp. Date	Citi Social and Behavioral Exp. Date	Citi Good Clinical Exp. Date	Staff Role	Email	Phone #	Organization/ Institution
Sally Thigpen	05/16/2025		10/19/2024		Project Coordinator	sti9@cdc.gov	770-488-3892	PROGRAM IMPLEMENTATION AND EVALUATION BRANCH

DMP
Proposed Data Collection Start Date	09/01/21
Proposed Data Collection End Date	07/31/26
Proposed Public Access Level	Public, Non-Public
Reason for not Releasing the Data	CIO conducting this project does not fund or own the data and is not responsible for making it available
Public Access justification	CDC will not publish data this is owned by funded jurisdictions. CDC may provide aggregate level data to the public that describes the program overall. Jurisdiction specific data will not be identified or released by CDC.
How Access Will Be Provided for Data	Only aggregate level data (at the recipient or program level) will be shared externally. No PII will be collected. Evaluation data will be published to the CDC website. Morbidity and mortality data will not be published to the CDC website. Jurisdictions will own this data and publish on their own websites. The jurisdiction data will be more timely and at a line level rather than analyzed/aggregate level data submitted to CDC.
Plans for archival and long-term preservation of the data	Will follow CDC records management guidelines

Spatiality (Geographic Location)
Country	State/Province	County/Region

Determinations
Determination	Justification	Completed	Entered By & Role
HSC: Does NOT Require HRPO Review	Not Research / Other 45 CFR 46.102(l) Program Evaluation	09/17/21	Angel_Karen C. (idy6) CIO HSC
PRA: PRA Applies		09/17/21	Angel_Karen C. (idy6) OMB / PRA